• Pioneering the Development of Therapeutic Antibodies for Alzheimer’s Disease
    Customers success stories

    Pioneering the Development of Therapeutic Antibodies for Alzheimer’s Disease

    Oumayma Rouis Oumayma Rouis 3 min read

    Neurodegenerative diseases such as Alzheimer’s are among the most complex and devastating disorders of our time, affecting millions worldwide. Identifying targets and developing effective therapies remains a formidable challenge for…

  1. CAR-T cell therapy

    From the first to the fifth generation of CAR-T cells

    Read more
  2. Customers success stories

    Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology

    Read more
  3. Antibody-drug conjugates

    ADC payloads

    Read more
  4. CAR-T cell therapy

    The structure of CAR-T cells

    Read more
  5. Customers success stories

    Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications

    Read more

Let’s talk about science – Scientists in the spotlight

Dr. Louisa James

“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”

Read more
Queen Mary University of London (QMUL, UK) Queen Mary University of London (QMUL, UK)
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Dr. Mara Freire

Reinventing IgY biotherapeutics

Read more
CICECO, University of Aveiro CICECO, University of Aveiro
Reinventing IgY biotherapeutics
Dr. Melanie Conrad

How the environment shapes immune system development during pregnancy

Read more
Charité Medical University in Berlin Charité Medical University in Berlin
How the environment shapes immune system development during pregnancy
Dr. Mohamed Alfaleh

“Cell-based phage display is helping us isolate more biologically relevant antibodies”

Read more
King Abdulaziz University King Abdulaziz University
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Prof. Tomáš Kalina

“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”

Read more
Charles University in Prague Charles University in Prague
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Prof. Richard Pleass

“Antibodies will make a significant contribution to design effective control strategies for COVID-19”

Read more
LSTM LSTM
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Professor Istvan Toth

“Simplicity is the key to successful large-scale applications”

Read more
Queensland University, Australia Queensland University, Australia
“Simplicity is the key to successful large-scale applications”
See More

Read by topic